Alzheimer Disease, Early Onset
57
18
26
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
1 terminated out of 57 trials
92.9%
+6.4% vs benchmark
4%
2 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (57)
Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
The Ketogenic Diet for Alzheimer's Disease
A Study to Assess THN391 in Subjects With Alzheimer's Disease
Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE